Core Lithium (ASX:CXO) said its cash balance stood at AU$91.6 million as of March 31, up from AU$48.7 million at Dec. 31, 2025, including tranche one of its equity raise, with a further about AU$37 million received post-quarter end from tranche one of the convertible note funding, according to a Thursday Australian bourse filing.

The company said the second tranche of the funding package, comprising an equity raise of AU$67 million and convertible notes of AU$62 million, both before costs, will "significantly" add to cash reserves, subject to shareholder approval at a general meeting convened for May 5, and Foreign Investment Review Board (FIRB) approval for the convertible notes.

Proceeds from the sale of the Finniss spodumene concentrate stockpile are not due to be received until June and are not included in the cash balance at the end of the quarter, the filing added.